Search
Search
David Eichenbaum, MD
Show Description +
David Eichenbaum, MD, reviews data from the HARBOR study, paying particular attention to patients with pigment epithelial detachments (PEDs). Dr. Eichenbaum explains that the study data point to a relationship between ranibizumab therapy and visual improvement in patients with PEDs in HARBOR, and that a significant number of patients saw PED resolution after ranibizumab therapy. However, as Dr. Eichenbaum points out, some of the HARBOR data raise as many questions as they answer.
Posted: 8/03/2016
David Eichenbaum, MD
David Eichenbaum, MD, reviews data from the HARBOR study, paying particular attention to patients with pigment epithelial detachments (PEDs). Dr. Eichenbaum explains that the study data point to a relationship between ranibizumab therapy and visual improvement in patients with PEDs in HARBOR, and that a significant number of patients saw PED resolution after ranibizumab therapy. However, as Dr. Eichenbaum points out, some of the HARBOR data raise as many questions as they answer.
Posted: 8/03/2016
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASRS: 2016.
Please log in to leave a comment.